Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("immunosuppressives")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 31891

  • Page / 1276
Export

Selection :

  • and

ENCAPSULATING PERITONEAL SCLEROSIS-MEDICAL AND SURGICAL TREATMENTWAI KEI LO; KAWANISHI, Hideki.Peritoneal dialysis international. 2009, Vol 29, issn 0896-8608, S211-S214, SUP2Conference Paper

Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis)PONGRATZ, Dieter.Journal of neurology. Supplement. 2006, Vol 253, Num 5, pp 64-65, issn 0939-1517, 2 p.Conference Paper

Idiopathic pulmonary haemosiderosis: An Oriental experienceYAO, T-C; HUNG, I-J; WONG, K-S et al.Journal of paediatrics and child health. 2003, Vol 39, Num 1, pp 27-30, issn 1034-4810, 4 p.Article

POSTTRANSPLANT ENCAPSULATING PERITONEAL SCLEROSIS : A WORRYING NEW TREND?FIEREN, Marien W. J. A; BETJES, Michiel G. H; KORTE, Mario R et al.Peritoneal dialysis international. 2007, Vol 27, Num 6, pp 619-624, issn 0896-8608, 6 p.Article

The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimensHATHAWAY, Donna; WINSETT, Rebecca; PRENDERGAST, Mary et al.Clinical transplantation. 2003, Vol 17, Num 3, pp 183-194, issn 0902-0063, 12 p.Article

Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II studySCOTT, Bart L; RAMAKRISHNAN, Aravind; FOSDAL, Mark et al.British journal of haematology. 2010, Vol 149, Num 5, pp 706-710, issn 0007-1048, 5 p.Article

Poor oral hygiene enhances gingival overgrowth caused by calcineurin inhibitorsREALI, L; ZULIANI, E; GABUTTI, L et al.Journal of clinical pharmacy and therapeutics (Print). 2009, Vol 34, Num 3, pp 255-260, issn 0269-4727, 6 p.Article

Susac's Syndrome : Intratympanic Therapy for Hearing Loss and a Review of the LiteratureCRAWLEY, Brianna K; CLOSE, Abby; CANTO, Cecilia et al.The Laryngoscope. 2009, Vol 119, Num 1, pp 141-144, issn 0023-852X, 4 p.Article

Mycophenolate mofetil (CellCept) : an alternative therapy for autoimmune inflammatory myopathyMAJITHIA, V; HARISDANGKUL, V.Rheumatology (Oxford. Print). 2005, Vol 44, Num 3, pp 386-389, issn 1462-0324, 4 p.Article

Pregnancy after renal transplantation: an evaluation of the graft functionAIVAZOGLOU, Lais; SASS, Nelson; SILVA JUNIOR, Hélio T et al.European journal of obstetrics, gynecology, and reproductive biology. 2011, Vol 155, Num 2, pp 129-131, issn 0301-2115, 3 p.Article

Scleromyxedema, a positive effect with thalidomideJACOB, Sharon E; FIEN, Sari; KERDEL, Francisco A et al.Dermatology (Basel). 2006, Vol 213, Num 2, pp 150-152, issn 1018-8665, 3 p.Article

Twenty-five years of immunosuppressionSCHWARTZ, R. S.Springer seminars in immunopathology. 1984, Vol 7, Num 1, pp 3-7, issn 0344-4325Article

(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivoRU ZHOU; FAN ZHANG; LI, Yuan-Chao et al.International immunopharmacology. 2005, Vol 5, Num 13-14, pp 1895-1903, issn 1567-5769, 9 p.Article

Immunosuppressive monoclonal antibodies: current and next generation : Monoclonal antibody therapy and viral infections: update and beyondFOCOSI, D; MAGGI, F; PISTELLO, M et al.Clinical microbiology and infection. 2011, Vol 17, Num 12, pp 1759-1768, issn 1198-743X, 10 p.Article

Operational tolerance after liver transplantationORLANDO, Giuseppe; SOKER, Shay; WOOD, Kathryn et al.Journal of hepatology. 2009, Vol 50, Num 6, pp 1247-1257, issn 0168-8278, 11 p.Article

Overcoming immunosuppressive mechanismsWIDEN, K; MOZAFFARI, F; CHOUDHURY, A et al.Annals of oncology. 2008, Vol 19, issn 0923-7534, vii241-vii247, SUP7Article

Five new C21 steroidal glycosides from Periploca sepiumLEI WANG; YIN, Zhi-Qi; ZHANG, Qing-Wen et al.Steroids. 2011, Vol 76, Num 3, pp 238-243, issn 0039-128X, 6 p.Article

New Immunosuppressive Protocols With the Advent of Novel Biological DrugsCRUZADO, Josep M; BESTARD, Oriol; GRINYO, Josep M et al.Transplantation. 2009, Vol 88, Num 3, issn 0041-1337, S20-S23, SUPConference Paper

Progress in immunosuppressionTransplantation proceedings. 1985, Vol 17, pp 35-78, issn 0041-1345, suppl. 2Article

From nonspecific to specific immunosuppression: facts and speculationBOREL, Y.Springer seminars in immunopathology. 1984, Vol 7, Num 1, pp 19-24, issn 0344-4325Article

Preserving Learned Immunosuppressive Placebo Response: Perspectives for Clinical ApplicationALBRING, A; WENDT, L; BENSON, S et al.Clinical pharmacology and therapeutics. 2014, Vol 96, Num 2, pp 247-255, issn 0009-9236, 9 p.Article

1,25-Dihydroxyvitamin D Exerts Similar Immunosuppressive Effects as UVR but Is Dispensable for Local UVR-Induced ImmunosuppressionSCHWARZ, Agatha; NAVID, Fatemeh; SPARWASSER, Tim et al.Journal of investigative dermatology. 2012, Vol 132, Num 12, pp 2762-2769, issn 0022-202X, 8 p.Article

International Conference on New Trends in Clinical and Experimental ImmunosuppressionTransplantation proceedings. 2001, Vol 33, Num 3, pp 2073-2403, issn 0041-1345, 316 p.Conference Proceedings

Identification of tolerant recipients following liver transplantationSANCHEZ-FUEYO, Alberto.International immunopharmacology (Print). 2010, Vol 10, Num 12, pp 1501-1504, issn 1567-5769, 4 p.Conference Paper

Fatigue and illness in athletesNIMMO, M. A; EKBLOM, B.Journal of sports sciences (Print). 2007, Vol 25, issn 0264-0414, S93-S102, SUP1Conference Paper

  • Page / 1276